• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Argenx(ARGX.US)

Overview
News
Financials
© 2026 Longbridge|Disclaimer

Event Tracking

Jan6
Citigroup Maintains Buy Rating on Argenx Se with Price Target
09:21
Jan5
H.C. Wainwright analyst maintains argenx buy rating
17:33
Dec17
RBC Capital Analyst Maintains Argenx Buy Rating
11:52
Dec16
Jefferies Analyst Maintains Buy Rating for Argenx Se with Price Target at $950
15:27
Dec15
arGEN-X SE Halts Phase III Clinical Trial of Efgartigimod for Thyroid Eye Disease
06:00
Dec5
Morgan Stanley Raises Argenx Price Target to $1,110
15:41

Schedules & Filings

Schedules
Filings
Oct30
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 1.151 B, Net Income 344.26 M, EPS 5.18

Jul31
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 967.19 M, Net Income 245.36 M, EPS 3.7403

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 807.37 M, Net Income 169.47 M, EPS 2.58

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
ANPA
53.660
+121.74%
+29.460
ATGL
37.880
+81.86%
+17.051
GP
1.231
+49.99%
+0.411
OPAD
2.190
+44.08%
+0.677
LRHC
1.120
+43.59%
+0.330
OPENW
1.764
+43.38%
+0.534
OPEX
23.210
+42.13%
+6.880
OPENL
1.105
+40.93%
+0.321
OPEG
16.570
+40.92%
+4.812
AKTS
25.000
+38.89%
+7.010
View More